Inventages Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 4
Professionals
  • Investments
  • 64
  • Portfolio
  • 9
  • Exits
  • 38
Exits

Inventages General Information

Description

Founded in 2000, Inventages is the venture capital arm of Nestlé and is based in Nassau, Bahamas. The firm seeks to invest in early-stage companies operating in the life sciences, nutrition, and wellness sectors.

Contact Information

Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • Caves Village, West Bay Street Building Number 5
  • Office Number 4, PO Box Number - 7532
  • Nassau, 7532
  • Bahamas
+1 (242) 000-0000

Inventages Investments (64)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cerecin 05-Oct-2018 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2 00000000 0000000000000
00 (00000 00000000 11-Jan-2016 00000 00000 000.00 Metal Containers and Packaging Generating Revenue 00000 000000
000000000 29-Sep-2014 00000 00000 000.00 Diagnostic Equipment Generating Revenue 000000 0000000 00.0
00-000000 10-Sep-2014 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3 00000 0000000000
000000 18-Oct-2012 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 1 00000 0000000000
00-0000 08-Oct-2012 00000 00000 Other Healthcare Services Out of Business
000000000 00000000 05-Mar-2012 00000 00000 000.00 Drug Discovery Bankruptcy: Admin/Reorg 000000 0000000000 00.0
000 (0000000000000 29-Sep-2011 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 000000 0000000 00.0
AM-Pharma 13-Sep-2011 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3 00000 0000000000
Shield Therapeutics 01-Jun-2011 Early Stage VC 000.00 Pharmaceuticals Generating Revenue/Not Profitable 000000 0000000000 00.0
You’re viewing 10 of 64 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventages Exits (38)

Company Name Exit Date Exit Type Exit Size
Biosys Health 05-Jan-2021 Out of Business
00000 00000 01-Feb-2020 000 00 00000000
000000 00000000000 13-Jan-2019 0000000000: 000000
000000000 01-Oct-2017 000 00 00000000
0000000000 01-Sep-2016 000000000000000000 00000
00000 11-Aug-2016 000000000000000000
000000 00000000000 26-Feb-2016 000 000.00
0000000 0000000 01-Jul-2015 000 00 00000000
Tanfield Food 20-Oct-2014 Buyout/LBO
Phosphate Therapeutics 01-Aug-2014 Bankruptcy: Admin/Reorg
You’re viewing 10 of 38 exits. Get the full list »

Inventages Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Inventages Team (33)

Name Title Deals Funds Boards Office
Gunnar Weikert Ph.D Founder, Chairman & Chief Executive Officer 0 0 0 London, United Kingdom
Thomas Bayerl Ph.D Venture Partner Nassau, Bahamas
Ashok Dhanrajgir Executive 0 0 0 Nassau, Bahamas
Wolfgang Reichenberger Executive 0 0 0 Nassau, Bahamas
Goetz Von Kalckreuth Ph.D Vice President of Human Resources London, United Kingdom
You’re viewing 5 of 33 team members. Get the full list »

Inventages Co-Investors (1)

Name With Exits Lead Partner Series Industry
Wilmar International 0 0 Series chart Industry bar
To view Inventages’s complete co-investors history, request access »